SLBT vs MDXG
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
SLBT · SL Science$0.55 ▼ 5.37%
MDXG · MiMedx$3.05 ▼ 1.93%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- SLBT -94.8%
- MDXG -55.0%
Head to head
| Metric | SLBT | MDXG |
|---|---|---|
| Price | $0.55 | $3.05 |
| Change today | ▼ 5.37% | ▼ 1.93% |
| Market cap | $308.42M | $445.07M |
| Return, 3 months | -79.7% | -28.6% |
| Return, year to date | -94.8% | -54.9% |
| Return, 1 year | -94.8% | -54.9% |
| P/E (TTM) | – | – |
| P/B | 45.8 | 2.1 |
| P/E percentile vs own 5y | 98th | 17th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | -34.7% | -45.2% |
| Net profit growth (YoY) | -220.6% | -151.8% |
| Gross margin | 38.4% | 77.3% |
| Operating margin | -178.8% | -8.3% |
| Net margin | -178.4% | -6.3% |
| Return on equity | -74.9% | -8.5% |
| Analyst target vs. price | – | +129.5% |
| Analyst buy share | – | 100% |
| RSI (14) | 21 | 22 |
| 30-day volatility | 118.1% | 66.2% |
| Max drawdown, 1 year | -95.7% | -60.4% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- MDXG is the largest of the group by market value.
- MDXG has returned the most over the past year.
- SLBT is growing revenue fastest.
- MDXG keeps the most profit per dollar of sales.
- MDXG has been the calmest stock over the last 30 days.